Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites

Journal of Hepatology

Volumn 46, Issue 2, 2007, Pages 213-221

  Kalambokis, Georgios ^a   Fotopoulos, Andreas ^a   Economou, Michalis ^a   Pappas, Konstantinos ^a   Tsianos, Epameinondas V ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Ascites; Cirrhosis; Renal function; Systemic haemodynamics; Urinary sodium excretion

Indexed keywords

ALDOSTERONE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; MIDODRINE; PLACEBO; SODIUM;

ADULT; AGED; ARTICLE; ASCITES; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SODIUM RETENTION; SPLANCHNIC BLOOD FLOW; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME; UREMIA; URINE VOLUME; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; CARDIOVASCULAR SYSTEM; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MIDODRINE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM; TREATMENT OUTCOME;

EID: 33845669928     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.09.012     Document Type: Article

References (43)

1. Schrier R.W., Arroyo V., Bernardi M., Epstein M., Henriksen J.H., and Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8 (1988) 1151-1157
2. Gines P., Fernandez-Esparrach G., Arroyo V., and Rodes J. Pathogenesis of ascites in cirrhosis. Semin Liv Dis 17 (1997) 175-189
3. Arroyo V., and Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 32 Suppl. 1 (2000) 157-170
4. Wong F., Liu P., Alidina Y., and Blendis L.M. Pattern of sodium handling and its consequences in pre-ascitic cirrhosis. Gastroenterology 108 (1995) 1820-1827
5. Wong F., Massie D., Hsu P., and Dudley F. Renal response to a saline load in well-compensated alcoholic cirrhosis. Hepatology 20 (1994) 873-881
6. La Villa G., Salmeron J.M., Arroyo V., Bosch J., Gines P., Garcia-Pagen J.C., et al. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology 102 (1992) 2114-2119
7. Iwao T., Toyonaga A., Sato M., Oho K., Sakai T., Tayama C., et al. Effect of posture-induced blood volume expansion on systemic and regional hemodynamics in patients with cirrhosis. J Hepatol 27 (1997) 484-491
8. Arroyo V., and Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysilogical basis of therapy and current management. J Hepatol 38 Suppl. (2003) 69-89
9. Moreau R., and Lebrec D. The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond. Hepatology 43 (2006) 385-394
10. Angeli P., Volpin R., Piovan D., Bortoluzzi A., Craighero R., Bottaro S., et al. Acute effects of the oral administration of midodrine, an α-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology 28 (1998) 937-943
11. Kalambokis G., Economou M., Fotopoulos A., Bokharhii J.A., Pappas C., Katsaraki F., and Tsianos E.V. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol 100 (2005) 879-885
12. Arroyo V., Gines P., Gerbes A.L., Dudley F.J., Gentilini P., Laffi G., et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23 (1996) 164-176
13. Kupari M., and Koskinen P. Systolic flow velocity profile in the left ventricular outflow tract in persons free of heart disease. Am J Cardiol 72 (1993) 1172-1178
14. Bernardi M., Li Bassi S., Arienti V., De Collimbus C., Scialpi C., Boriani L., et al. Systemic and regional hemodynamics in pre-ascitic cirrhosis: effects of posture. J Hepatol 39 (2003) 502-508
15. Andersen U.B., Moller S., Bendtsen F., and Henriksen J.H. Cardiac output determined by echocardiography in patients with cirrhosis: comparison with the indicator dilution technique. Eur Gastroenterol Hepatol 15 (2003) 503-507
16. Blaufox M.D. Measurement of renal function with radioactive materials. In: Blaufox M.D. (Ed). Evaluation of renal function and disease with radionuclides. The upper urinary tract (1989), Karger, Basel 12-27
17. Rehling M., Moller M.L., Thamdrup B., Lund J.O., and Trap-Jensen J. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci 66 (1984) 613-619
18. Levey A.S., Madaio M.P., and Perrone R.D. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In: Brenner B.M., and Rector Jr. F.C. (Eds). The Kidney (1991), Saunders, Philadelphia 919-968
19. Mulkay J.P., Louis H., Donckier V., Bourgeois N., Adler M., Deviere J., and Le Moine O. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study. Acta Gastroenterol Belg 64 (2001) 15-19
20. Duvoux C., Zanditenas D., Hézode C., Chauvat A., Monin J.L., Roudot-Thoraval F., et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome. Hepatology 36 (2002) 374-380
21. Angeli P., Volpin R., Craighero R., Roner P., Merenda R., Amodio P., et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29 (1999) 1690-1697
22. Therapondos G., Stanley A.J., and Hayes P.C. Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: apilot study. J Gastroenterol Hepatol 19 (2004) 73-77
23. Kalambokis G., Economou M., Kosta P., Papadimitriou K., Pappas C., Katsaraki A., and Tsianos E.V. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis. J Gastroenterol Hepatol 20 (2005) 1075-1081
24. Lancestremere R.G., Klinger Jr. E.L., Frisch E., and Paper S. Simultaneous determination of cardiac output and renal function in patients with Laennec's cirrhosis during the administration of the pressor amine metaraminol. J Lab Clin Med 61 (1963) 820-825
25. Gutman R.A., Forrey A.W., Fleet W.P., and Cutler R.E. Vasopressor-induced natriuresis and altered intrarenal haemodynamics in cirrhotic man. Clin Sci Mol Med 45 (1973) 19-34
26. Shapiro M.D., Nicholls M.K., Groves B.M., Kludge R., Chung H.M., Bichet D.G., et al. Interrelationship between cardiac output and vascular resistance as determinants of effective arterial blood volume in cirrhotic patients. Kidney Int 28 (1985) 206-211
27. Badalamenti S., Borroni G., Lorenzano E., Incerti P., and Salerno F. Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion. Hepatology 15 (1992) 824-829
28. McTavish D., and Goa Kl. Midodrine. A review of its pharmacological and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs 38 (1989) 757-777
29. Low P.A., Gilden J.L., Freeman R., and McElligott M.A. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. JAMA 277 (1997) 1046-1051
30. Tsuchida K., Yamazaki R., Kaneko K., and Aihara H. Effects of midodrine on blood flow in dog vascular beds. Arzneimittelforschung 36 (1986) 1745-1748
31. Wong F., Pantea L., and Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 40 (2004) 55-64
32. Bernardi M., Trevisani F., Santini C., De Palma R., and Gasbarrini G. Aldosterone-related blood volume expansion before and after ascites formation in cirrhosis of the liver. Gut 24 (1983) 761-766
33. Bernardi M., Di Marco C., Trevisani F., Fornale L., Andreone P., Cursaro C., et al. Renal sodium retention during upright posture in pre-ascitic cirrhosis. Gastroenterology 105 (1993) 188-193
34. Bernardi M., and Trevisani F. Systemic and regional hemodynamics in preascitic cirrhosis. J Hepatol 27 (1997) 588-591
35. Bernardi M., Di Marco C., Trevisani F., De Collibus C., Fornale L., Baraldini M., et al. The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change. Hepatology 16 (1992) 341-346
36. Wong F., Liu P., Alidina Y., and Blendis L.M. The effects of sodium restriction and posture on central blood volume in pre-ascitic cirrhosis. Hepatology 23 (1996) 1141-1147
37. Trevisani F., Bernardi M., Casbarrini A., Tame M.R., Giancane S., Andreone P., et al. Bed-rest induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintained "compensation"?. J Hepatol 16 (1992) 190-196
38. Wong F., Sniderman K., and Blendis L.M. The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis. Gastroenterology 115 (1998) 397-405
39. Trevisani F., Bernardi M., De Palma R., Pancione L., Capani F., Baraldini M., et al. Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympathoadrenergic tone, and intratubular factors. Gastroenterology 96 (1989) 1187-1198
40. Fernandez-Llama P., Ageloff S., Fernandez-Varo G., Ros J., Wang X., Garra N., et al. Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins. Kidney Int 67 (2005) 622-630
41. Elhawary A.M., and Pang C.C. Alpha 1b-adrenoreceptors mediate renal tubular sodium and water reabsorption in the rat. Br J Pharmacol 111 (1994) 819-824
42. MacGilchrist A.J., Summer D., and Reid J.L. Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular effect. Hepatology 13 (1991) 689-694
43. Albillos A., Lledo J.L., Rossi I., Perez-Paramo M., Tabuenca M.J., Banares R., et al. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function. Gastroenterology 109 (1995) 1257-1265